According to a new report by Expert Market Research, the CDMO Market shows strong expansion potential, supported by increasing pharmaceutical outsourcing, advanced manufacturing requirements, and evolving healthcare needs. The market was valued at USD 246.11 Billion in 2025 and is projected to grow at a CAGR of 9.1% during 2026–2035, reaching USD 588.0 Billion by 2035.

The detailed study of the highlights the role of contract development and manufacturing organisations in supporting pharmaceutical innovation, production efficiency, and specialised capabilities.

The market growth is influenced by rising demand for outsourced development solutions, increasing complexity of therapies, and the need for reliable manufacturing partnerships. Companies are focusing on quality systems, regulatory alignment, and flexible production models to strengthen their market position.

View a Sample Report – Includes Full Table of Contents

Expert Market Research presents a comprehensive outlook covering market dynamics, segmentation, competitive developments, and industry trends. The analysis reflects how CDMO providers support pharmaceutical and biopharmaceutical companies through integrated services and specialised expertise.

Market Overview

The CDMO industry connects pharmaceutical innovators with specialised service providers offering development and manufacturing support. Expert Market Research evaluates the changing landscape of the sector, including outsourcing strategies, technological advancements, and the growing need for efficient production networks. The market continues to evolve as companies seek partners capable of supporting complex therapeutic development and commercial manufacturing.

Market Size & Forecast: Expert Market Research Projections

Expert Market Research states that the CDMO Market size was USD 246.11 Billion in 2025 and is expected to expand at a CAGR of 9.1% during 2026–2035, reaching a forecast value of USD 588.0 Billion by 2035. The growth outlook reflects increasing adoption of outsourced services, enhanced manufacturing capabilities, and stronger demand for specialised pharmaceutical support.

Macroeconomic & Industry Linkage Analysis

Macroeconomic factors influencing the sector include healthcare investment, pharmaceutical innovation, and the global shift toward efficient supply networks. CDMO providers help companies manage development requirements while improving access to specialised infrastructure.

The industry is also linked with changing therapeutic needs and rising expectations for faster delivery of pharmaceutical solutions. Expert Market Research identifies outsourcing as a key strategic approach supporting operational flexibility and long term competitiveness.

Key Growth Drivers

• Pharmaceutical Outsourcing: Growing preference for external expertise supports demand for development and manufacturing partnerships.
• Advanced Manufacturing Capabilities: Improved technologies enable CDMO providers to deliver specialised production support.
• Therapeutic Innovation: Increasing complexity of therapies encourages collaboration with experienced service providers.
• Cost Efficiency: Companies seek solutions that optimise resources and improve operational effectiveness.
• Regulatory Support: Strong quality and compliance capabilities strengthen adoption of CDMO services.

Market Trends

The CDMO sector is experiencing greater demand for integrated solutions that combine research support, development expertise, and manufacturing capabilities. Providers are expanding service portfolios to meet changing customer expectations.

Expert Market Research highlights the importance of strategic investments, technology adoption, and specialised production capabilities in shaping future market direction. Companies are strengthening their offerings to support diverse pharmaceutical requirements.

Market Challenges & Risk Factors

The market faces challenges related to complex production processes, evolving compliance expectations, and the need for continuous investment in specialised capabilities.

Supply chain coordination and maintaining consistent quality standards remain important considerations for organisations operating across pharmaceutical development and manufacturing activities.

Market Opportunities & White Space Areas

Opportunities exist through expanding outsourcing adoption, specialised manufacturing services, and partnerships across pharmaceutical and biotechnology sectors. New areas of innovation continue to create demand for flexible CDMO solutions.

Expert Market Research notes that providers with broad capabilities and strong technical expertise are positioned to capture emerging opportunities in the evolving healthcare ecosystem.

Value Chain & Supply Chain Analysis

The CDMO value chain includes research support, development activities, manufacturing operations, quality processes, and delivery coordination. Efficient collaboration among stakeholders improves service reliability and supports pharmaceutical product advancement.

Market Segmentation Analysis

Service Type

• Contract Manufacturing Organization
• Contract Research Organization

Therapeutic Area

• Oncological Diseases
• Cardiovascular Diseases
• Infectious Diseases
• Others

End User

• Pharmaceutical and Biopharmaceutical Companies
• Medical Devices Companies
• Others

Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Competitive Landscape

Key companies covered in the CDMO Market include Vetter Pharma-Fertigung GmbH & Co. KG, Recipharm AB, Boehringer Ingelheim, Patheon Pharma Services (Thermo Fisher Scientific Inc.), Pfizer Inc., Famar SA, Lonza Group, LTS Lohmann Therapie-Systeme AG, Aenova Holding GmBH, Fareva SA, FUJIFILM Diosynth Biotechnologies, eXmoor Pharma, B. Braun SE, and Sanofi.

Frequently Asked Questions (FAQs)

What is the current size of the CDMO Market?
The CDMO Market was valued at USD 246.11 Billion in 2025.

What is the projected CAGR of the CDMO Market?
The CDMO Market is projected to grow at a CAGR of 9.1% during 2026–2035.

Which region dominates the CDMO Market?
North America, Europe, Asia Pacific, Latin America, and Middle East and Africa are key regional areas covered in the analysis.

Who are the key players in the CDMO Market?
Key players include Vetter Pharma-Fertigung GmbH & Co. KG, Recipharm AB, Boehringer Ingelheim, Patheon Pharma Services (Thermo Fisher Scientific Inc.), Pfizer Inc., Famar SA, Lonza Group, LTS Lohmann Therapie-Systeme AG, Aenova Holding GmBH, Fareva SA, FUJIFILM Diosynth Biotechnologies, eXmoor Pharma, B. Braun SE, and Sanofi.

What are the major growth drivers of the CDMO Market?
Major growth drivers include pharmaceutical outsourcing, advanced manufacturing capabilities, therapeutic innovation, cost efficiency, and regulatory support.

What are the key segments of the CDMO Market?
The market is segmented by service type, therapeutic area, end user, and region.

What challenges does the CDMO Market face?
The market faces challenges related to complex production requirements, compliance expectations, and maintaining efficient supply chains.

What is the forecast value of the CDMO Market by 2035?
The CDMO Market is forecast to reach USD 588.0 Billion by 2035.

”

About Us:

Expert Market Research is a global market intelligence and consulting platform by Claight delivering data-driven insights across commodities, chemicals, energy, and industrial markets. We design our research to support businesses, analysts, investors, and procurement teams in understanding price trends, supply-demand dynamics, competitive landscapes, gaining competitive intelligence, benchmarking best practices, and developing long-term market outlooks.

Our robust research methodologies, combined with validated primary and secondary data, ensure accuracy, consistency, and relevance. Our analysis is widely used not only for strategic planning, market-entry assessments, and sourcing decisions, but also for investment evaluation across international markets. Our strong emphasis on transparency, factual reporting, and regular data updates to reflect real-time market conditions always keeps you ahead of the curve.

Media Contact:

Company Name: Claight Corporation
Email: sales@expertmarketresearch.com
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: C-130 Sector 2 Noida, Uttar Pradesh 201301
Website: https://www.expertmarketresearch.com